SILODOSIN 8mg. IP

An alpha-1 blocker that is approved for the treatment of benign prostatic hyperplasia with lower urinary tract symptoms. (R. Manjunatha, 2016) An efficacious agent for the initial management of patients suffering from lower urinary tract symptoms. (U Capitanio, 2013) Produces effective symptomatic improvement in subjects with benign prostatic hyperplasia associated with lower urinary tract symptoms. (R. Manjunatha, 2016) A rapidly efficacious and safe agent in the treatment of benign prostatic hyperplasia with lower urinary tract symptoms in men. (Nadir I Osman, 2012) An effective and well-tolerated treatment for the relief of both voiding and storage symptoms in patients with lower urinary tract symptoms suggestive of bladder outlet obstruction. (Ch R Chapple, 2012) Provides rapid improvements in the signs and symptoms of moderate to severe lower urinary tract symptoms due to benign prostatic hyperplasia in male patients. (Júlio Fonseca, 2015) The treatment of choice for the management of lower urinary tract symptoms in elderly men who are taking antihypertensive drugs. (Woo Suk Choi, 2017)